Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hila Cohen

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Viruses|April 3, 2021
Neutralizing Monoclonal Anti-SARS-CoV-2 Antibodies Isolated from Immunized Rabbits Define Novel Vulnerable Spike-Protein EpitopeEfi Makdasi, Yinon Levy, Ron Alcalay, et al.
Science Advances|March 8, 2023
A single-dose F1-based mRNA-LNP vaccine provides protection against the lethal plague bacteriumEdo Kon, Yinon Levy, Uri Elia, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|May 9, 2022
Immune Response to Third Dose BNT162b2 COVID-19 Vaccine Among Kidney Transplant Recipients-A Prospective StudyDafna Yahav, Ruth Rahamimov, Tiki Mashraki, et al.
Pathogens (Basel, Switzerland)|August 28, 2021
Implementation of Adenovirus-Mediated Pulmonary Expression of Human ACE2 in HLA Transgenic Mice Enables Establishment of a COVID-19 Murine Model for Assessment of Immune Responses to SARS-CoV-2 InfectionTheodor Chitlaru, Erez Bar-Haim, Liat Bar-On, et al.
The American Journal of Tropical Medicine and Hygiene|October 22, 2024
A Novel Virulent Clinical Isolate of Burkholderia pseudomallei Imported from Thailand Exhibiting Resistance to Trimethoprim-SulfamethoxazoleSharon Amit, David Gur, Moshe Aftalion, et al.
Vaccines|April 28, 2023
Immunogenicity of a Third Dose of BNT162b2 Vaccine among Lung Transplant Recipients-A Prospective Cohort StudyYael Shostak, Mordechai R Kramer, Omer Edni, et al.
Archives of Toxicology|January 15, 2022
Preliminary nonclinical safety and immunogenicity of an rVSV-ΔG-SARS-CoV-2-S vaccine in mice, hamsters, rabbits and pigsNoa Madar-Balakirski, Amir Rosner, Sharon Melamed, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Viruses|April 3, 2021
Neutralizing Monoclonal Anti-SARS-CoV-2 Antibodies Isolated from Immunized Rabbits Define Novel Vulnerable Spike-Protein EpitopeEfi Makdasi, Yinon Levy, Ron Alcalay, et al.
Science Advances|March 8, 2023
A single-dose F1-based mRNA-LNP vaccine provides protection against the lethal plague bacteriumEdo Kon, Yinon Levy, Uri Elia, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|May 9, 2022
Immune Response to Third Dose BNT162b2 COVID-19 Vaccine Among Kidney Transplant Recipients-A Prospective StudyDafna Yahav, Ruth Rahamimov, Tiki Mashraki, et al.
Pathogens (Basel, Switzerland)|August 28, 2021
Implementation of Adenovirus-Mediated Pulmonary Expression of Human ACE2 in HLA Transgenic Mice Enables Establishment of a COVID-19 Murine Model for Assessment of Immune Responses to SARS-CoV-2 InfectionTheodor Chitlaru, Erez Bar-Haim, Liat Bar-On, et al.
The American Journal of Tropical Medicine and Hygiene|October 22, 2024
A Novel Virulent Clinical Isolate of Burkholderia pseudomallei Imported from Thailand Exhibiting Resistance to Trimethoprim-SulfamethoxazoleSharon Amit, David Gur, Moshe Aftalion, et al.
Vaccines|April 28, 2023
Immunogenicity of a Third Dose of BNT162b2 Vaccine among Lung Transplant Recipients-A Prospective Cohort StudyYael Shostak, Mordechai R Kramer, Omer Edni, et al.
Archives of Toxicology|January 15, 2022
Preliminary nonclinical safety and immunogenicity of an rVSV-ΔG-SARS-CoV-2-S vaccine in mice, hamsters, rabbits and pigsNoa Madar-Balakirski, Amir Rosner, Sharon Melamed, et al.
Pageof 3